Magnetic helmet trial aims to slow deadly brain tumors

NCT ID NCT06533163

Recruiting now Disease control Sponsor: BioTex, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot trial tests a portable, wearable device that delivers low-intensity magnetic therapy to people with newly diagnosed glioblastoma, an aggressive brain cancer. The study will enroll 30 adults who have had surgery and are able to receive standard radiotherapy. The main goal is to check the device's safety, but researchers will also monitor tumor response on MRI scans and progression-free survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Oncomagnetic device (wearable magnetic therapy device)
What this could lead to: If it works, this could point toward a noninvasive way to slow glioblastoma growth alongside standard care.
What could go wrong: This is a very early pilot trial with only 30 people, focused on safety. It may not show any benefit, and the device is not a proven treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glioblastoma glioma susceptibility 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLIOBLASTOMA MULTIFORME

Contacts and locations

Locations

Clinical Center Lünen
RECRUITING

Lünen, North Rhine-Westphalia, 44534, Germany
Clinical Center Stuttgart
RECRUITING

Stuttgart, Baden-Wurttemberg, 70174, Germany
Medical Center Mannheim
RECRUITING

Mannheim, 68167, Germany
Technical University of Munich
RECRUITING

München, Bavaria, 81675, Germany
University Hospital Bonn
RECRUITING

Bonn, North Rhine-Westphalia, 53127, Germany
University Hospital Leipzig
RECRUITING

Leipzig, Saxony, 04103, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.